ATM–Chk2–p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency
- 4 May 2006
- journal article
- Published by Springer Nature in The EMBO Journal
- Vol. 25 (10) , 2167-2177
- https://doi.org/10.1038/sj.emboj.7601115
Abstract
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.Keywords
This publication has 47 references indexed in Scilit:
- Oncogene-induced senescence as an initial barrier in lymphoma developmentNature, 2005
- Senescence in premalignant tumoursNature, 2005
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast CancerJNCI Journal of the National Cancer Institute, 2003
- UV Irradiation Triggers Ubiquitin-Dependent Degradation of p21WAF1 to Promote DNA RepairCell, 2003
- Normal lymphocyte development and thymic lymphoma formation in Brca1 exon-11-deficient miceOncogene, 2003
- Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoformGenes & Development, 2003
- Ageing and apoptosisPublished by Elsevier ,2001
- Partial rescue of Brca15–6 early embryonic lethality by p53 or p21 null mutationNature Genetics, 1997